Simplex Trading’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-300
| Closed | -$1.35K | – | 9246 |
|
|
2025
Q4 | $1.35K | Buy |
+300
| New | +$1.54K | ﹤0.01% | 7954 |
|
|
2025
Q3 | – | Sell |
-400
| Closed | -$2K | – | 9209 |
|
|
2025
Q2 | $2K | Sell |
400
-7,400
| -95% | -$29.3K | ﹤0.01% | 8105 |
|
|
2025
Q1 | $21K | Sell |
7,800
-5,800
| -43% | -$20.2K | ﹤0.01% | 6533 |
|
|
2024
Q4 | $46K | Buy |
13,600
+7,700
| +131% | +$22.2K | ﹤0.01% | 5957 |
|
|
2024
Q3 | $17K | Buy |
5,900
+2,800
| +90% | +$9.22K | ﹤0.01% | 6789 |
|
|
2024
Q2 | $10K | Sell |
3,100
-4,300
| -58% | -$14.1K | ﹤0.01% | 7406 |
|
|
2024
Q1 | $22K | Sell |
7,400
-64,100
| -90% | -$225K | ﹤0.01% | 7010 |
|
|
2023
Q4 | $301K | Buy |
71,500
+63,500
| +794% | +$344K | ﹤0.01% | 4219 |
|
|
2023
Q3 | $54K | Sell |
8,000
-6,600
| -45% | -$58.3K | ﹤0.01% | 5732 |
|
|
2023
Q2 | $152K | Sell |
14,600
-42,200
| -74% | -$377K | ﹤0.01% | 4609 |
|
|
2023
Q1 | $395K | Buy |
56,800
+38,700
| +214% | +$337K | ﹤0.01% | 3522 |
|
|
2022
Q4 | $109K | Buy |
18,100
+2,000
| +12% | +$14.8K | ﹤0.01% | 4958 |
|
|
2022
Q3 | $126K | Sell |
16,100
-15,100
| -48% | -$176K | ﹤0.01% | 5215 |
|
|
2022
Q2 | $424K | Buy |
31,200
+12,500
| +67% | +$207K | ﹤0.01% | 3652 |
|
|
2022
Q1 | $366K | Sell |
18,700
-15,300
| -45% | -$306K | ﹤0.01% | 4272 |
|
|
2021
Q4 | $1.17M | Sell |
34,000
-17,000
| -33% | -$684K | ﹤0.01% | 2667 |
|
|
2021
Q3 | $3.46M | Sell |
51,000
-4,500
| -8% | -$271K | ﹤0.01% | 1532 |
|
|
2021
Q2 | $4.08M | Buy |
55,500
+54,758
| +7,380% | +$5.47M | ﹤0.01% | 1372 |
|
|
2021
Q1 | $6.79M | Buy |
+742
| New | +$72K | 0.01% | 622 |
|
|
2020
Q4 | – | Sell |
-178
| Closed | -$828K | – | 8441 |
|
|
2020
Q3 | $828K | Buy |
+178
| New | +$9.93K | ﹤0.01% | 2450 |
|
Simplex Trading's CVAC Position: Q4 2025 in Review
Simplex Trading sold out of CureVac (CVAC) in Q4 2025, closing a stake of 14,903 shares — an estimated $76.3K sold.
Simplex Trading first reported a position in CVAC in Q4 2020 and held it in 15 quarters. The position peaked at $391K in Q1 2022. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.
- Simplex Trading reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 14,903 CureVac shares in Q4 2025, an estimated $76.3K.
- Simplex Trading first reported a position in CureVac in Q4 2020 and held it in 15 quarters.
- Simplex Trading's CureVac position peaked at $391K in Q1 2022.
- 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.